Hence, we hypothesized that SRGN/YAP signaling induces chemoresistance via other mechanisms, and focused on epigenetic-related molecules such as HDACs (histone deacetylases) because of their critical roles in tumorigenesis, tumor progression, and therapeutic response 24, 42. This evidence concerns the gene SRGN and neoplasm.